Teknova Inc (TKNO): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand Alpha Teknova Inc (TKNO)

Alpha Teknova, Inc. (TKNO) demonstrates a disciplined approach to the production of critical reagents with transparent quality control. Management is successfully scaling capacity to meet the needs of advanced laboratories. The company's P/S ratio clearly reflects market expectations, with the current parameter standing at 9.70. Future margin growth is expected to be driven by the stabilization of cell therapy media production as demand recovers.

Price-to-Revenue Ratio: Teknova (TKNO) for 07/04/2022 - 11/13/2026

Metric breakdowns and analytics for Alpha Teknova Inc (TKNO)

- stock quotes and analyst forecast:
Price teknova.com|TKNO - Price Target Chart
- stock exchange capitalization data:
Market Value Alpha Teknova Inc|TKNO - Real Price to Acquire Entire Company
- book capitalization indicators:
Book Value per Share Teknova|TKNO - Company Book Value|Market Cap to Net Assets Ratio teknova.com|TKNO - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital Alpha Teknova, Inc.|TKNO - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Teknova Inc|TKNO - Company Total Debt|Debt to Book Capital Alpha Teknova Inc|TKNO - Company Long-Term Debt|Short-Term Debt Volume Teknova|Quick Ratio teknova.com
- company profitability and valuation multiples indicators:
TKNO - Company Net Income|Expected Profit Alpha Teknova, Inc.|TKNO - Price to Earnings Ratio|Price to Expected Earnings Ratio Alpha Teknova|TKNO - PEG Multiple|Business Value to Operating Income Before Depreciation Alpha Teknova Inc|TKNO - Operating profit EBITDA|Net earnings per share (EPS TTM) Teknova|TKNO - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months teknova.com|TKNO - Net earnings per share growth this year|Projected earnings per share increase next year Alpha Teknova, Inc.
- total revenue and sales volume data:
TKNO - Revenue and Sales Volume|Company Expected Sales Volume teknova.com|TKNO - Price-to-Revenue Ratio|Forward P/S Multiple Alpha Teknova Inc
Summary company analytics:teknova.com
Mass-produced product of teknova.com

Investors must determine the fair value of Alpha Teknova, Inc. (TKNO) by comparing market capitalization with actual sales volume to avoid overpaying for the asset. By analyzing the P/S ratio dynamics on the GURU.Markets platform, one can assess the value of each dollar of revenue, which in this case is supported by stable demand for laboratory reagents and the company's steady operating cash flow.

Competitors of Alpha Teknova, Inc.

Market Cap to Sales Volume ISRG|Price-to-Revenue Ratio Danaher DHR|Market Capitalization-to-Revenue Ratio BDX|STE: Market Cap to Revenue|WST - P/S Multiple|Baxter International (BAX) - Price-to-Revenue Ratio|Market Cap to Revenue masimo.com|STVN (Stevanato Group) - P/S Multiple|Price to Sales Teleflex Inc. TFX|Price-to-Revenue Ratio Merit Medical Systems Inc (MMSI)|Nobel Biocare - Market Cap to Revenue Ratio|ICU Medical, Inc. - Market Cap to Revenue|Market Cap to Sales Volume XRAY (dentsplysirona.com)|LMAT - Price-to-Revenue Ratio|Price-to-Revenue Coefficient AtriCure Inc ATRC|STAA: P/S Multiple|Niagen (NAGE) - P/S Multiple|Price-to-Revenue Ratio ZimVie Inc.|Price-to-Revenue Ratio ANGO|Price-to-Revenue Ratio Cerus (CERS)|MGRM: Price-to-Sales Ratio|P/S Multiple STSS (Sharps Technology)|Market Capitalization-to-Revenue Ratio INFU|Utah Medical Products - P/S Multiple|KRMD - P/S Multiple|NYXH (Nyxoah) - Market Cap to Revenue|Microbot Medical, Inc. - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue PDEX|ZTEK (Zentek Corp) - Market Cap to Sales Volume|P/S Multiple ELUT|MLSS - Price to Sales|Price-to-Revenue Ratio NEXGEL NXGL|P/S Multiple Retractable Technologies Inc. RVP|HBIO - Price-to-Revenue Ratio|FEMY (Femasys Corporation) - Market Cap to Revenue Ratio|meihuamed.com (MHUA) - Price-to-Revenue Ratio|Price to Sales Predictive Oncology Inc. (POAI)|Market Cap to Revenue CJMB|Price-to-Revenue Ratio ATRI|P/S Multiple NURO